JPY 604.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.6 Billion JPY | 13.63% |
2022 | 2.29 Billion JPY | 10.75% |
2021 | 2.06 Billion JPY | 27.45% |
2020 | 1.62 Billion JPY | 5.53% |
2019 | 1.53 Billion JPY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 2.6 Billion JPY | 13.63% |
2023 Q4 | 2.6 Billion JPY | 4.37% |
2023 Q3 | 2.49 Billion JPY | 13.29% |
2023 Q2 | 2.2 Billion JPY | 4.36% |
2023 Q1 | 2.1 Billion JPY | -7.91% |
2022 Q4 | 2.29 Billion JPY | 1.7% |
2022 Q3 | 2.25 Billion JPY | 13.07% |
2022 Q2 | 1.99 Billion JPY | 4.68% |
2022 Q1 | 1.9 Billion JPY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 76.3 Billion JPY | 96.588% |
DNA Chip Research Inc. | 982.47 Million JPY | -164.983% |
Cosmo Bio Company,Limited | 10.87 Billion JPY | 76.054% |
H.U. Group Holdings, Inc. | 295.35 Billion JPY | 99.119% |
FALCO HOLDINGS Co., Ltd. | 36.42 Billion JPY | 92.853% |
BML, Inc. | 170.99 Billion JPY | 98.477% |
Precision System Science Co., Ltd. | 6.39 Billion JPY | 59.3% |